SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-019462
Filing Date
2024-07-10
Accepted
2024-07-10 16:11:28
Documents
1
Period of Report
2024-07-08

Document Format Files

Seq Description Document Type Size
1 form4-07102024_080725.html 4  
1 form4-07102024_080725.xml 4 6593
  Complete submission text file 0001415889-24-019462.txt   8128
Mailing Address 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080 650-392-8412
SUTRO BIOPHARMA, INC. (Issuer) CIK: 0001382101 (see all company filings)

IRS No.: 452441988 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O SUTRO BIOPHARMA, INC. 111 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address
Leyman Barbara (Reporting) CIK: 0002028309 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38662 | Film No.: 241110098